Literature DB >> 13092274

Metabolism of plasma expanders studied with carbon-14-labeled dextran.

I GRAY.   

Abstract

Entities:  

Keywords:  DEXTRAN/metabolism

Mesh：

Substances：

Year:  1953        PMID： 13092274     DOI： 10.1152/ajplegacy.1953.174.3.462

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  7 in total

1.  [Causes of dextran retention in the rat].

Authors:  T DIAMANTSTEIN; H EHRHART
Journal:  Klin Wochenschr       Date:  1962-05-01

2.  [Pharmacocinetics and dosage of dextran 40 in relation to renal function (author's transl)].

Authors:  H Köhler; W Kirch; D Höffler; P Koeppe
Journal:  Klin Wochenschr       Date:  1974-12-01

3.  Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics.

Authors:  Jessica L Cohen; Stephanie Schubert; Peter R Wich; Lina Cui; Joel A Cohen; Justin L Mynar; Jean M J Fréchet
Journal:  Bioconjug Chem       Date:  2011-05-24       Impact factor: 4.774

Review 4.  Targeting the C-type lectins-mediated host-pathogen interactions with dextran.

Authors:  Sergey Pustylnikov; Divya Sagar; Pooja Jain; Zafar K Khan
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

Review 5.  Clinical pharmacokinetic considerations in the use of plasma expanders.

Authors:  U Klotz; H Kroemer
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

6.  Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5.

Authors:  H Kroemer; A Haass; K Müller; H Jäger; E M Wagner; P Heimburg; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Effects of different plasma expanders on rats subjected to severe acute normovolemic hemodilution.

Authors:  Guo-Xing You; Bing-Ting Li; Zhen Wang; Quan Wang; Ying Wang; Jing-Xiang Zhao; Lian Zhao; Hong Zhou
Journal:  Mil Med Res       Date:  2020-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.